4.5 Article

The Latin America and the Caribbean Consortium on Dementia (LAC-CD): From Networking to Research to Implementation Science

Journal

JOURNAL OF ALZHEIMERS DISEASE
Volume 82, Issue -, Pages S379-S394

Publisher

IOS PRESS
DOI: 10.3233/JAD-201384

Keywords

Dementia; genetics; implementation science; LAC-CD; Latin America; neurodegeneration; neuroimaging; regional health; social determinants of health; socioeconomic status

Categories

Funding

  1. Alzheimer's Association [GBHI ALZ UK-20-639295]
  2. Takeda [CW2680521]
  3. CONICET
  4. Sistema General de Regalias [BPIN2018000100059]
  5. Universidad del Valle [CI 5316]
  6. MULTI-PARTNER CONSORTIUM TO EXPAND DEMENTIA RESEARCH IN LATIN AMERICA [ReDLat by National Institutes of Health, National Institutes of Aging] [R01 AG057234]
  7. MULTI-PARTNER CONSORTIUM TO EXPAND DEMENTIA RESEARCH IN LATIN AMERICA [ReDLat by Rainwater Charitable foundation -Tau Consortium]
  8. MULTI-PARTNER CONSORTIUM TO EXPAND DEMENTIA RESEARCH IN LATIN AMERICA [ReDLat by Global Brain Health Institute]
  9. MRC [MRC-R42552]
  10. Alzheimer's Society [AS-R42303, AS-SF-14-008]
  11. Medical Research Council [MR/K010395/1]
  12. MULTI-PARTNER CONSORTIUM TO EXPAND DEMENTIA RESEARCH IN LATIN AMERICA [ReDLat by Alzheimer's Association] [SG-20-725707]
  13. [ANID/FONDAP/15150012]
  14. MRC [MR/K010395/1] Funding Source: UKRI

Ask authors/readers for more resources

Dementia prevalence in Latin America is rapidly increasing, leading to clinical, social, and economic burdens for patients and their families. The Latin America and the Caribbean Consortium on Dementia (LAC-CD) is a regional organization aiming to oversee and promote clinical and research activities on dementia in the region. Coordination of efforts is crucial to address the challenges posed by dementia in Latin America and to improve healthcare systems and research collaborations.
In comparison with other regions, dementia prevalence in Latin America is growing rapidly, along with the consequent clinical, social, and economic burden upon patients and their families. The combination of fragile health care systems, large social inequalities, and isolated clinical and research initiatives makes the coordination of efforts imperative. The Latin America and the Caribbean Consortium on Dementia (LAC-CD) is a regional organization overseeing and promoting clinical and research activities on dementia. Here, we first provide an overview of the consortium, highlighting the antecedents and current mission. Then, we present the consortium's regional research, including the multi-partner consortium to expand dementia research in Latin America (ReDLat), which aims to identify the unique genetic, social, and economic factors that drive Alzheimer's and frontotemporal dementia presentation in LAC relative to the US. We describe an extension of ReDLat which aims to develop affordable markers of disease subtype and severity using high density EEG. We introduce current initiatives promoting regional diagnosis, visibility, and capacity, including the forthcoming launch of the Latin American Brain Health Institute (BrainLat). We discuss LAC-CD-led advances in brain health diplomacy, including an assessment of responses to the impact of COVID-19 on people with dementia and examining the knowledge of public policies among experts in the region. Finally, we present the current knowledge-to-action framework, which paves the way for a future regional action plan. Coordinated actions are crucial to forging strong regional bonds, supporting the implementation of regional dementia plans, improving health systems, and expanding research collaborations across Latin America.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available